药品详细
Oxandrolone(氧甲氢龙)
化学结构式图
中文名
氧甲氢龙
英文名
Oxandrolone
分子式
C19H30O3
化学名
(1S,2S,7S,10R,11S,14S,15S)-14-hydroxy-2,14,15-trimethyl-4-oxatetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-5-one
分子量
Average: 306.4397
Monoisotopic: 306.219494826
Monoisotopic: 306.219494826
CAS号
53-39-4
ATC分类
A14A 未知
药物类型
small molecule
阶段
approved
商品名
同义名
基本介绍
A synthetic hormone with anabolic and androgenic properties. [PubChem]
生产厂家
- Par pharmaceutical inc
- Roxane laboratories inc
- Sandoz inc
- Savient pharmaceuticals inc
- Upsher smith laboratories inc
封装厂家
- A-S Medication Solutions LLC
- BTG Pharmaceuticals Corp.
- DSM Corp.
- Eon Labs
- Letco Medical Inc.
- Murfreesboro Pharmaceutical Nursing Supply
- Par Pharmaceuticals
- Pharmaceutics International Inc.
- Physicians Total Care Inc.
- Resource Optimization and Innovation LLC
- Sandoz
- Savient Pharmaceuticals
- Upsher Smith Laboratories
- Watson Pharmaceuticals
参考
Synthesis Reference | Not Available |
General Reference |
|
剂型
规格
化合物类型
Type | small molecule |
Classes |
|
Substructures |
|
适应症
药理
Indication | Use to promote weight gain after weight loss following extensive surgery. |
Pharmacodynamics | Oxandrolone is an anabolic steroids indicated as adjunctive therapy to promote weight gain after weight loss following extensive surgery, chronic infections, or severe trauma, and in some patients who without definite pathophysiologic reasons fail to gain or to maintain normal weight, to offset the protein catabolism associated with prolonged administration of corticosteroids, and for the relief of the bone pain frequently accompanying osteoporosis. Anabolic steroids are synthetic derivatives of testosterone. |
Mechanism of action | Oxandrolones interact with androgen receptors in target tissues. |
Absorption | Not Available |
Volume of distribution | Not Available |
Protein binding | Not Available |
Metabolism |
Renal
|
Route of elimination | Not Available |
Half life | 0.55 hours (1st phage), 9 hours (2nd phase) |
Clearance | Not Available |
Toxicity | The oral LD50 of oxandrolone in mice and dogs is greater than 5,000 mg/kg. |
Affected organisms |
|
Pathways | Not Available |
理化性质
Properties | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
State | solid | |||||||||||||||||||||||||||||||||||||||
Experimental Properties |
|
|||||||||||||||||||||||||||||||||||||||
Predicted Properties |
|
药物相互作用
Drug | Interaction |
---|---|
Warfarin | Oxandrolone may increase the serum concentration and anticoagulant effect of warfarin. Monitor for changes in prothrombin time and therapeutic effects of warfarin if oxandrolone is initiated, discontinued or dose changed. |
食物相互作用
Not Available